H.R. 8819 mandates that federal agencies adopt and utilize the Artificial Intelligence Risk Management Framework established by the National Institute of Standards and Technology (NIST) when implementing artificial intelligence technologies. This framework is intended to guide agencies in managing risks associated with AI, ensuring that such technologies are used safely and responsibly.
Supporters of H.R. 8819 have praised the bill for promoting a standardized approach to AI risk management across federal agencies. They argue that this will enhance accountability and safety in the deployment of AI technologies, ultimately leading to more effective and ethical use of AI in government operations.
Critics of H.R. 8819 have expressed concerns that the bill could lead to bureaucratic delays and hinder innovation in the AI sector. Some argue that the requirements may be overly restrictive and could stifle the development of new technologies by imposing a one-size-fits-all framework that may not be suitable for all applications.
The analysis of H.R. 8819, which mandates the use of the Artificial Intelligence Risk Management Framework by federal agencies, reveals no direct industry overlaps between the bill's subject matter and the top donor industries of sponsor Ted Lieu. The lobbying activity in this policy area primarily involves healthcare and telecommunications industries, with significant contributions such as $60,000 from Vertex Pharmaceuticals and $50,000 from Intermountain Health. However, these industries do not have a direct connection to the artificial intelligence framework outlined in the bill. As a result, the potential for conflicts of interest appears minimal, given the lack of alignment between the sponsors' financial backers and the bill's focus on AI risk management.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | MARSHALL & POPP, LLC | $60,000 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | MARSHALL & POPP, LLC | $60,000 |
| INTERMOUNTAIN HEALTH | MCDERMOTT WILL & SCHULTE LLP | $50,000 |
| GILLETTE CHILDREN'S SPECIALTY HEALTHCARE | MCDERMOTT+ LLC | $40,000 |
| FRONTIER INFRASTRUCTURE HOLDINGS LLC | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| ECKERD CONNECTS | KOUNTOUPES DENHAM CARR & REID, LLC | $30,000 |
| SMART APPROACHES TO MARIJUANA | OFF HILL STRATEGIES L.L.C. | $20,000 |
| FEDERATION OF ELECTRIC POWER COS OF JAPAN | GEORGE H. DENISON | $10,000 |
| MAYO CLINIC | MCDERMOTT WILL & SCHULTE LLP | undisclosed |
| VERIZON COMMUNICATIONS, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG TEN CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| THE BIG 12 CONFERENCE, INC. | MARSHALL & POPP, LLC | undisclosed |
| SOUTHEASTERN CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| PAC-12 CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
| ATLANTIC COAST CONFERENCE | MARSHALL & POPP, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Ted Lieu, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
